pravastatin
普伐他汀
常用释义
英音[ ˌprɑːvəˈstatɪn ]
美音[ pˈreɪvəsteɪtɪn ]
基本释义
- 普伐他汀
例句
-
1·Objective: To compare the lipid - regulating effects of fluvastatin and pravastatin.目的：比较氟伐他汀和普伐他汀调整血脂的临床效果。
-
2·Conclusion: the method is practical and can be used for the pharmacokinetic study of pravastatin.结论：方法实用有效，可用于药代动力学研究。
-
3·OBJECTIVE To study the intestinal absorption and liver distribution characters of pravastatin in rats.目的研究普伐他汀在大鼠小肠吸收及肝脏分布特征。
-
4·The area of plaques and intima media thickness in CHD group were thinner after treatment of pravastatin.应用普伐他汀治疗后，冠心病患者的斑块积分和内中膜厚度均有所减小；
-
5·CONCLUSIONS The pravastatin not only can regulate blood lipid, but also can improve hemorheology in patients with hyperlipidemia.结论：普伐他汀不仅能明显降低血脂，而且能改善患者的血液流变性。
-
6·Conclusion: the early benefit of pravastatin in enhancing atherosclerosis regression was partly due to the improvement of platelet function.结论：普伐他汀促进动脉粥样硬化斑块消退的早期效益是由于对血小板功能的良性影响而产生。
-
7·Conclusion Pravastatin can be safely used for treating metabolic syndrome because it can ameliorate the lipid disturbance, hypertension and microalbuminuria.结论普伐他汀可改善代谢综合征患者的血脂紊乱、高血压及微量白蛋白尿，可安全地应用于代谢综合征患者。
-
8·Conclusion pravastatin could control and delay the morphological changes of diabetic retinopathy, and pravastatin could decreased the expression of MCP-1 in diabetic retina.结论普伐他汀能够阻止或延缓糖尿病视网膜形态改变；普伐他汀能够减弱糖尿病大鼠视网膜组织中MCP - 1的表达。
-
9·Conclusion Pravastatin can decrease blood lipid dramatically, relieve atherosclerosis, improve endothelium function and enhance the total treatment efficiency rate for angina.结论普伐他汀降脂疗效显著，可减轻动脉粥样硬化的程度，改善血管内皮功能，使心绞痛治疗疗效明显提高。
-
10·Objective Investigation on the changes of the microcirculation and blood rheology after using pravastatin and exploration of the effects other than lowering the level of blood lipid.目的研究普伐他汀对冠心病的微循环及血液流变性影响，探讨其降脂外作用。